• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Ophthalmology

Risk score system accurate in predicting macular degeneration risk

bySwarup Swaminathan, MDandAndrew Bishara
March 21, 2014
in Ophthalmology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. 8 predictors (age, sex, education level, race, smoking status, presence of pigment abnormality, soft drusen, and maximum drusen size) were utilized to create a macular risk scoring system (MRSS).

2. Area under the receiver operating characteristic (ROC) curve was excellent (internally validated c-index = 0.88; externally validated c-index = 0.91). Sensitivity and specificity at cutoff of 0 were 87.6% and 73.6% respectively.

Evidence Rating Level: 2 (Good)

Study Rundown: In this retrospective study, the authors created the macular risk scoring system (MRSS) to help clinicians in assessing how likely patients may develop age-related macular degeneration (AMD). Two large AMD datasets, the age-related eye disease study (AREDS) and blue mountain eye study (BMES), were utilized to identify crucial parameters for the study. Utilizing various statistical methods, the MRSS was created with a sensitivity and specificity of 87.6% and 73.6% respectively with a cutoff of 0. This is the first risk scoring system that also uses incidence data to help predict risk up to 10 years in the future. The authors also provide specificity & sensitivity for various cutoffs, providing flexibility users. Limitations are mostly based on the limitations of BMES & AREDS, which include limited number of AMD cases and a narrow study population respectively.

Click to read the study in Ophthalmology

Relevant Reading: Prediction Model for Prevalence and Incidence of Advanced Age-Related Macular Degeneration Based on Genetic, Demographic, and Environmental Variables

RELATED REPORTS

Novel anti-VEGF agent provides additional benefit when combined with ranibizumab for neovascular age-related macular degeneration

Age-related macular degeneration may be associated with depression risk

Risk of hydroxychloroquine retinopathy increases with longer use and higher dosage

In-Depth [retrospective study]: This study attempted to identify a scoring system to assess risk of developing age-related macular degeneration. Two prior databases, AREDS and BMES, were utilized, and 5 demographic predictors (age, sex, education level, race, smoking status) and 3 ophthalmic predictors (presence of pigment abnormality, soft drusen, and maximum drusen size) were identified. Specific scores were assigned depending on the patient’s phenotype for each parameter. A logistic regression model was used to create the MRSS. The c-index, which represents of the area under the ROC curve, was 0.88-0.91 depending on the validation technique, which represents a very good model. Overall, the MRSS provides a valuable tool to assess whether patients are low or high-risk, allowing the physician to alter monitoring as needed.

More from this author: Argus II retinal prosthesis significantly improves spatial vision in blind patients, Artificial cornea is well retained in patients with ocular surface disease, High prevalence of undiagnosed glaucoma in West Africa, Interferon therapy is superior to methotrexate for uveitis, Rho kinase inhibitor safely reduces intraocular pressure

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: Age-Related Eye Disease Studyage-related macular degenerationOphthalmology
Previous Post

Substantial differences seen in antibiotic use among non-EU European countries

Next Post

Stool DNA testing may improve screening sensitivity of colorectal cancer

RelatedReports

Patient Basics: Macular Degeneration
Ophthalmology

Novel anti-VEGF agent provides additional benefit when combined with ranibizumab for neovascular age-related macular degeneration

February 20, 2023
Antioxidants, omega-3 lack benefit in age-related macular degeneration
Ophthalmology

Age-related macular degeneration may be associated with depression risk

February 6, 2023
Blindness and visual impairment decreasing worldwide
Chronic Disease

Risk of hydroxychloroquine retinopathy increases with longer use and higher dosage

February 1, 2023
Antioxidants, omega-3 lack benefit in age-related macular degeneration
Ophthalmology

Meta-analysis shows significant decrease in age-related macular degeneration risk with metformin use

December 19, 2022
Next Post
RAS mutation linked with survival in metastatic colorectal cancer

Stool DNA testing may improve screening sensitivity of colorectal cancer

Nationwide treatment regimen more than halves tuberculosis prevalence in China

Nationwide treatment regimen more than halves tuberculosis prevalence in China

Obtaining consent for c-section during labor may be suboptimal

Cesarean in the second stage associated with endometritis

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring
  • Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma
  • Lebrikizumab effective in treating moderate-to-severe atopic dermatitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options